TransMedics Group Inc (TMDX)
US Market

TransMedics Group (TMDX) Financial Statements


TransMedics Group Financial Overview

TransMedics Group's market cap is currently ―. The company's EPS TTM is $-1.491; its P/E ratio is -45.51; TransMedics Group is scheduled to report earnings on March 6, 2023, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 25.68M$ 20.52M$ 15.88M$ 9.67M$ 5.37M
Gross Profit$ 18.11M$ 14.35M$ 12.10M$ 6.99M$ 3.77M
EBIT$ -6.62M$ -10.53M$ -9.60M$ -11.67M$ -11.97M
EBITDA$ -5.73M$ -9.73M$ -9.09M$ -11.21M$ -11.52M
Net Income Common Stockholders$ -7.43M$ -11.52M$ -10.56M$ -12.67M$ -12.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 204.46M$ 58.08M$ 72.00M$ 92.45M$ 102.86M
Total Assets$ 274.87M$ 117.28M$ 124.01M$ 134.89M$ 131.15M
Total Debt$ 67.73M$ 45.00M$ 45.18M$ 43.80M$ 35.06M
Net Debt$ -136.73M$ -13.09M$ -26.82M$ -48.65M$ -67.80M
Total Liabilities$ 87.02M$ 66.37M$ 64.10M$ 67.04M$ 52.60M
Stockholders Equity$ 187.86M$ 50.92M$ 59.91M$ 67.85M$ 78.55M
Cash Flow-
Free Cash Flow$ -17.21M$ -13.35M$ -20.36M$ -9.83M$ -9.42M
Operating Cash Flow$ -14.28M$ -9.09M$ -18.41M$ -6.65M$ -9.35M
Investing Cash Flow$ 24.75M$ 22.02M$ 10.51M$ 9.99M$ 6.20M
Financing Cash Flow$ 164.22M$ 237.00K$ 405.00K$ 45.00K$ 552.00K
Currency in USD

TransMedics Group Earnings and Revenue History

TransMedics Group Debt to Assets

TransMedics Group Cash Flow

TransMedics Group Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis